Arnuity Ellipta: Medgend

Arnuity Ellipta FDA Approved Drugs

ARNUITY ELLIPTA [Fluticasone Furoate^{C₂₇H₂₉F₃O₆S}]

0.1mg/inh (inhalation powder)

0.2mg/inh (inhalation powder)

Glaxosmithkline^{Aug 20, 2014}

Indicated for the once-daily maintenance treatment of asthma as prophylactic therapy in patients aged 12 years of age and older.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

FLONASE SENSIMIST ALLERGY RELIEF [Fluticasone Furoate^{C₂₇H₂₉F₃O₆S}]

OTC

0.0275mg/spray (nasal spray, metered)

Glaxosmithkline Cons^{Aug 2, 2016}

Otc use: allergy symptom reliever; temporarily relieves these symptoms due to hay fever or other upper respiratory allergies; nasal congestion, runny nose, sneezing, itchy nose, and (itchy water eyes (ages 12 and up)).
The treatment of the symptoms of seasonal and perennial allergic rhinitis in patients 2 years of age and older.
Treatment of rhinitis comprising the nasal application of a pharmaceutical formulation as claimed in us patent 7541350.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.